1. Home
  2. VERU vs SPCB Comparison

VERU vs SPCB Comparison

Compare VERU & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • SPCB
  • Stock Information
  • Founded
  • VERU 1971
  • SPCB 1988
  • Country
  • VERU United States
  • SPCB Israel
  • Employees
  • VERU N/A
  • SPCB N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • SPCB Semiconductors
  • Sector
  • VERU Health Care
  • SPCB Technology
  • Exchange
  • VERU Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • VERU 54.6M
  • SPCB 48.0M
  • IPO Year
  • VERU 1990
  • SPCB N/A
  • Fundamental
  • Price
  • VERU $2.88
  • SPCB $11.01
  • Analyst Decision
  • VERU Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • VERU 3
  • SPCB 1
  • Target Price
  • VERU $33.33
  • SPCB $18.00
  • AVG Volume (30 Days)
  • VERU 182.9K
  • SPCB 86.6K
  • Earning Date
  • VERU 12-15-2025
  • SPCB 11-14-2025
  • Dividend Yield
  • VERU N/A
  • SPCB N/A
  • EPS Growth
  • VERU N/A
  • SPCB N/A
  • EPS
  • VERU N/A
  • SPCB 0.98
  • Revenue
  • VERU $16,886,419.00
  • SPCB $27,426,000.00
  • Revenue This Year
  • VERU N/A
  • SPCB N/A
  • Revenue Next Year
  • VERU N/A
  • SPCB $29.31
  • P/E Ratio
  • VERU N/A
  • SPCB $11.66
  • Revenue Growth
  • VERU 337.24
  • SPCB 2.17
  • 52 Week Low
  • VERU $2.64
  • SPCB $3.05
  • 52 Week High
  • VERU $14.20
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • VERU 32.50
  • SPCB 49.67
  • Support Level
  • VERU $2.76
  • SPCB $10.82
  • Resistance Level
  • VERU $3.99
  • SPCB $11.79
  • Average True Range (ATR)
  • VERU 0.29
  • SPCB 0.67
  • MACD
  • VERU -0.17
  • SPCB 0.02
  • Stochastic Oscillator
  • VERU 11.23
  • SPCB 57.24

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: